Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Metapex Plus

K-Number: K202617 · 2021-04-14

Decision Date2021-04-14
Product CodeKIF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Metapex Plus is a medical device manufactured by Meta Biomed Co., Ltd.. It received FDA 510(k) clearance on 2021-04-14 under approval number K202617. The device is classified under product code KIF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Metapex Plus?

Metapex Plus is a medical device that received FDA 510(k) clearance on 2021-04-14. It is manufactured by Meta Biomed Co., Ltd.. The 510(k) number is K202617.

When was Metapex Plus approved by the FDA?

Metapex Plus received FDA 510(k) clearance on 2021-04-14, under approval number K202617.

What company makes Metapex Plus?

Metapex Plus is manufactured by Meta Biomed Co., Ltd..

What is the FDA product code for Metapex Plus?

The FDA product code for Metapex Plus is KIF.

Other Devices by Meta Biomed Co., Ltd.

View all 13 devices →

Related Devices (Code: KIF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.